MTOR and neuroblastoma: In addition, signaling through the IGF1R/PI3 kinase/AKT/mTOR pathway facilitates neuroblastoma metastasis to bone [30] and induces resistance to cytotoxic chemotherapy, retinoic acid, and ALK inhibitors [31,32,33].